Covaxin found to neutralise 617 variant of Covid-19: Dr Fauci

B.1.617, is a triple mutant variant, which some parts of India are dealing with.

Covaxin, India's home-grown COVID-19 vaccine, has been found to neutralise the 617 variant of the deadly virus, White House chief medical adviser and America's top pandemic expert Dr Anthony Fauci made the statement.


"This is something where we're still gaining data on a daily basis. But the most recent data, was looking at convalescent Sera of COVID-19 cases and people who received the vaccine used in India, the Covaxin. It was found to neutralise the 617 variant," he said.


B.1.617, is a triple mutant variant, which some parts of India are dealing with. It is also being called the Bengal variant.


"So, despite the real difficulty that we're seeing in India, vaccination could be a very, very important antidote against this," Fauci added.


According to the New York Times, Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.


Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3. Trial results later showed the vaccine has an efficacy of 78 percent.

 

India Scanner News Network

Leave a comment